StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.25−0.11 (-8.09%)

Close on Nov 20, 2026Market cap $79.66MP/E –Yield –

TuHURA Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

TuHURA Biosciences's pe ratio was 0.3× on Jul 31, 2019, against 0.8× a year earlier. Over the last 3 years it ranged from 0.2× to 14.1×, with a median of 1.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jul 31, 20190.3×−0.4
2018Dec 31, 20180.7×−0.2
2017Dec 29, 20170.9×−2.6
2016Dec 30, 20163.5×–

More TuHURA Biosciences figures

See a number that looks wrong?